Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cyclooxygenase-2: The future is now

Nature Medicine volume 4, pages 773–774 (1998)Cite this article

A new generation of NSAIDs selectively and irreversibly inhibits cyclooxygenase-2—an enzyme that regulates several cellular processes involved in colon cancer development including angiogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Giardiello, F.M. et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N, Engl. J. Med. 328, 1313–1316 (1993).

    Article  CAS  Google Scholar 

  2. Sniff, S.J. & Rigas, B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Castroenterology 113, 1992–1998 (1998).

    Google Scholar 

  3. Piazza, G.A. et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57, 2909–2915 (1997).

    CAS  PubMed  Google Scholar 

  4. Kalgutkar, A.S. et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science 280, 1268–1270 (1998).

    Article  CAS  PubMed  Google Scholar 

  5. Oshima, M. et al. Suppression of intestinal polyposis in APC delta 716 knockout mice by inhibition of prostaglandin endoperoxidase-2 (COX-2). Cell 87, 803–809 (1996).

    Article  CAS  PubMed  Google Scholar 

  6. Sheng, H. et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99, 2254–2259 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Reddy B.S., Rao, C.V. & Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56, 4566–4569 (1996).

    CAS  PubMed  Google Scholar 

  8. Tsujii, M. & DuBois, R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83, 493–501 (1995).

    Article  CAS  PubMed  Google Scholar 

  9. Tsujii, M., Kuwano, S. & s DuBois, R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA 94, 3336–3340 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705–716 (1998).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA

    Anil K. Rustgi

Authors
  1. Anil K. Rustgi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rustgi, A. Cyclooxygenase-2: The future is now. Nat Med 4, 773–774 (1998). https://doi.org/10.1038/nm0798-773

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0798-773

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing